Review



software version 9.9  (MathWorks Inc)


Bioz Verified Symbol MathWorks Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    MathWorks Inc software version 9.9
    Software Version 9.9, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/software version 9.9/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    software version 9.9 - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    imaris software version 9 9  (Oxford Instruments)
    99
    Oxford Instruments imaris software version 9 9
    Imaris Software Version 9 9, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/imaris software version 9 9/product/Oxford Instruments
    Average 99 stars, based on 1 article reviews
    imaris software version 9 9 - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    dynamic pbpk modeling software gastroplustm version 9.9  (Simulations Plus Inc)
    90
    Simulations Plus Inc dynamic pbpk modeling software gastroplustm version 9.9
    Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
    Dynamic Pbpk Modeling Software Gastroplustm Version 9.9, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dynamic pbpk modeling software gastroplustm version 9.9/product/Simulations Plus Inc
    Average 90 stars, based on 1 article reviews
    dynamic pbpk modeling software gastroplustm version 9.9 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    software version 9.9  (MathWorks Inc)
    90
    MathWorks Inc software version 9.9
    Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
    Software Version 9.9, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/software version 9.9/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    software version 9.9 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    origin software version 9.9  (OriginLab corp)
    90
    OriginLab corp origin software version 9.9
    Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
    Origin Software Version 9.9, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/origin software version 9.9/product/OriginLab corp
    Average 90 stars, based on 1 article reviews
    origin software version 9.9 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    presentation software version 9.9  (neurobehavioral systems inc)
    90
    neurobehavioral systems inc presentation software version 9.9
    Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
    Presentation Software Version 9.9, supplied by neurobehavioral systems inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/presentation software version 9.9/product/neurobehavioral systems inc
    Average 90 stars, based on 1 article reviews
    presentation software version 9.9 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    r2020b (version 9.9) software  (MathWorks Inc)
    90
    MathWorks Inc r2020b (version 9.9) software
    Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and <t>PBPK</t> model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.
    R2020b (Version 9.9) Software, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/r2020b (version 9.9) software/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    r2020b (version 9.9) software - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.

    Journal: Frontiers in Pharmacology

    Article Title: High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis

    doi: 10.3389/fphar.2025.1555276

    Figure Lengend Snippet: Model simulations of vancomycin concentration-time profiles from four studies in the training dataset: (A) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young US population. (B) Observed and PBPK model simulated vancomycin plasma concentrations after a single 1,000 mg intravenous dose in a young Chinese population. (C) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the HC group. (D) Observed and PBPK model simulated vancomycin plasma concentrations after multiple 1,000 mg doses every 12 h in the LC group.

    Article Snippet: To assess pharmacokinetics and tissue distribution of vancomycin in PJI patients, we employed the commercially available dynamic PBPK modeling software GastroPlusTM version 9.9 (Simulations Plus, Inc.) to construct a stepwise model as previously described ( ).

    Techniques: Concentration Assay, Clinical Proteomics

    The model to predict vancomycin concentrations in the red marrow, yellow marrow and kidney: (A) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the HC group. (B) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the LC group. (C) Observed and PBPK model simulated concentrations in plasma and kidney in the HC group. (D) Observed and PBPK model simulated concentrations in plasma and kidney in the LC group.

    Journal: Frontiers in Pharmacology

    Article Title: High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis

    doi: 10.3389/fphar.2025.1555276

    Figure Lengend Snippet: The model to predict vancomycin concentrations in the red marrow, yellow marrow and kidney: (A) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the HC group. (B) Observed and PBPK model simulated concentrations in plasma, red marrow, and yellow marrow in the LC group. (C) Observed and PBPK model simulated concentrations in plasma and kidney in the HC group. (D) Observed and PBPK model simulated concentrations in plasma and kidney in the LC group.

    Article Snippet: To assess pharmacokinetics and tissue distribution of vancomycin in PJI patients, we employed the commercially available dynamic PBPK modeling software GastroPlusTM version 9.9 (Simulations Plus, Inc.) to construct a stepwise model as previously described ( ).

    Techniques: Clinical Proteomics